Quanterix announced “Simoa Accelerator” – a dedicated laboratory environment for clinical sample testing and development allowing broader access to an advanced diagnostic technology that has been fueling research in oncology, neurology, cardiology, infectious disease, etc.
Quanterix announced the opening of The Simoa Accelerator.
CRF Health announced an agreement with EuroQol to launch the EQ-5D web system on its TrialMax Web software platform.
Agreement expands innovative data collection offerings for biopharmaceutical clients
WIRB-Copernicus Group announced that it has been chosen by Cancer Treatment Centers of America to expand its clinical research program.
Strategy will enable CTCA to expand its clinical research capabilities while maintaining the highest standard of human subject protection
It’s clear that the value clinical trials bring to the health and well being of our existence is being recognized and expectations from the public are high.
The development and approval of new vaccines and antivirals to contain and treat the Ebola virus outbreak has become a top priority for the federal government and Congress.
An effective risk mitigation model requires the development of a structured approach to risk identification, analysis and control, from trial inception to completion.
As clinical games emerge as a new tool for diagnosing and treating cognitive health, it is important to understand how these tools work and the ways in which these tools are validated, as well as how to realize their full potential.
EFPIA is pleased to announce today the official appointment of Joe Jimenez, CEO of Novartis, as its new President.
EFPIA has announced the official appointment of Joe Jimenez, CEO of Novartis, as its new President.
The European Forum for GCP (EFGCP) Geriatric Medicines Working Party is organizing a multi-stakeholder workshop, “Excluded Older People from Clinical Research”
SCRS announced a two-year collaboration with Clinical Ink.
Acquisition Enriches Medidata’s Comprehensive Risk-Based Monitoring Solution, Enabling Safer, Faster and More Insightful Clinical Trial Reviews
SCRS announced a two-year collaboration with Clinical Ink
Medidata announced the availability is enriched solution for risk-based monitoring.
PCORI is launching a $50 million program to fund research on the comparative effectiveness of various approaches for diagnosing and treating hepatitis C.
TrialScope announced the latest release of its PharmaCM platform (v.2.2)
TrialScope announced general availability of the latest release of the PharmaCM platform
Comprehend CEO Rick Morrison shares his thoughts on 2015 predictions for clinical R&D.
The conclusions on vaccination that European Union health ministers adopted on December 1 contain several sound thoughts.
Clinical trials need to become a part of the treatment continuum, not separated from it as it is now.
Company to fund new SCRS Scholarship Program to improve site sustainability through education; becomes first CRO to leverage Site Advocacy Group to improve clinical development process
Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research
Leading Global CRO Expands into Western Europe, Establishes its European Headquarters in Frankfurt, Germany
BBK Worldwide and ACRES are collaborating to ensure that patients are a central part of the organization's efforts in standards development
For each clinical trial, a clinical trial agreement and budget are negotiated between the investigator and the sponsoring company so that the costs of carrying out the trial are reimbursed.